However, it seems that our results are reliable and consistent with the data reported previously, indicating that SCD1 (along with other genes encoding lipogenic enzymes) is highly overexpressed in numerous cancers, and that the level of the expression is associated with clinical features. This evidence concerns the gene SCD and cancer.